| 000 | 01512 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513171238.0 | ||
| 264 | 0 | _c19990419 | |
| 008 | 199904s 0 0 eng d | ||
| 022 | _a0006-2960 | ||
| 024 | 7 |
_a10.1021/bi9823481 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDoussiere, J | |
| 245 | 0 | 0 |
_aThe heme component of the neutrophil NADPH oxidase complex is a target for aryliodonium compounds. _h[electronic resource] |
| 260 |
_bBiochemistry _cMar 1999 |
||
| 300 |
_a3694-703 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBiphenyl Compounds _xpharmacology |
| 650 | 0 | 4 | _aCattle |
| 650 | 0 | 4 |
_aCell Membrane _xdrug effects |
| 650 | 0 | 4 |
_aCytochrome b Group _xchemistry |
| 650 | 0 | 4 |
_aDithionite _xmetabolism |
| 650 | 0 | 4 | _aElectron Spin Resonance Spectroscopy |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aFlavin-Adenine Dinucleotide _xchemistry |
| 650 | 0 | 4 |
_aHeme _xchemistry |
| 650 | 0 | 4 |
_aNADPH Oxidases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNeutrophils _xdrug effects |
| 650 | 0 | 4 |
_aOnium Compounds _xpharmacology |
| 650 | 0 | 4 | _aOxidation-Reduction |
| 650 | 0 | 4 |
_aOxygen Consumption _xdrug effects |
| 650 | 0 | 4 | _aSpectrometry, Fluorescence |
| 650 | 0 | 4 | _aSpectrophotometry |
| 700 | 1 | _aGaillard, J | |
| 700 | 1 | _aVignais, P V | |
| 773 | 0 |
_tBiochemistry _gvol. 38 _gno. 12 _gp. 3694-703 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/bi9823481 _zAvailable from publisher's website |
| 999 |
_c10050489 _d10050489 |
||